These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6539877)

  • 1. Verapamil in prophylactic therapy of migraine.
    Markley HG; Cheronis JC; Piepho RW
    Neurology; 1984 Jul; 34(7):973-6. PubMed ID: 6539877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verapamil prophylaxis of migraine. A double-blind, placebo-controlled study.
    Solomon GD; Steel JG; Spaccavento LJ
    JAMA; 1983 Nov; 250(18):2500-2. PubMed ID: 6355533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil in migraine prophylaxis--a five-year review.
    Solomon GD
    Headache; 1989 Jul; 29(7):425-7. PubMed ID: 2668225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine prophylactic drugs: proof of efficacy, utilization and cost.
    Ramadan NM; Schultz LL; Gilkey SJ
    Cephalalgia; 1997 Apr; 17(2):73-80. PubMed ID: 9137841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of verapamil in the treatment of hemicrania without aura].
    Fonzari M; Santoloci D; Farinini D
    Clin Ter; 1994 Apr; 144(4):329-32. PubMed ID: 8205756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the effects of verapamil, flunarizine, diltiazem, nimodipine and placebo in the prevention of hemicrania. A double-blind randomized cross-over study].
    Paterna S; Martino SG; Campisi D; Cascio Ingurgio N; Marsala BA
    Clin Ter; 1990 Jul; 134(2):119-25. PubMed ID: 2147612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil and migraine prophylaxis: mechanisms and efficacy.
    Markley HG
    Am J Med; 1991 May; 90(5A):48S-53S. PubMed ID: 2039020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migraine prevention with timolol. A double-blind crossover study.
    Stellar S; Ahrens SP; Meibohm AR; Reines SA
    JAMA; 1984 Nov; 252(18):2576-80. PubMed ID: 6387197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of calcium channel blocking agents in the prevention of migraine.
    Schuler ME; Goldman MP; Munger MA
    Drug Intell Clin Pharm; 1988 Mar; 22(3):187-91. PubMed ID: 3284729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
    Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
    Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prophylactic treatments of migraine].
    Massiou H
    Rev Neurol (Paris); 2000; 156 Suppl 4():4S79-86. PubMed ID: 11139754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of calcium-antagonist drugs in the preventive therapy of migraine. Experience with verapamil].
    Centonze V; Campanozzi F; Macinagrossa G; Attolini E; Magrone D; Tesauro P; Vino M; Albano O
    Minerva Med; 1987 Jul; 78(14):1103-5. PubMed ID: 3601160
    [No Abstract]   [Full Text] [Related]  

  • 14. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double blind comparison of lithium and verapamil in cluster headache prophylaxis.
    Bussone G; Leone M; Peccarisi C; Micieli G; Granella F; Magri M; Manzoni GC; Nappi G
    Headache; 1990 Jun; 30(7):411-7. PubMed ID: 2205598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acupuncture for the prevention of episodic migraine.
    Linde K; Allais G; Brinkhaus B; Fei Y; Mehring M; Vertosick EA; Vickers A; White AR
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001218. PubMed ID: 27351677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants related to successful migraine prophylaxis with verapamil.
    Cutrer FM; Moyer AM; Atkinson EJ; Wang L; Tian S; Wu Y; Garza I; Robertson CE; Huebert CA; Moore BE; Klein CJ
    Mol Genet Genomic Med; 2021 Jun; 9(6):e1680. PubMed ID: 33829662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.